The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 2051 -2062
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0802577

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takenouchi, T.
Right arrow Articles by Hashimoto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takenouchi, T.
Right arrow Articles by Hashimoto, M.

The Activation of P2X7 Receptor Impairs Lysosomal Functions and Stimulates the Release of Autophagolysosomes in Microglial Cells1

Takato Takenouchi*,{dagger}, Masaaki Nakai{dagger}, Yoshifumi Iwamaru{ddagger}, Shuei Sugama{dagger},§, Mitsutoshi Tsukimoto, Masayo Fujita{dagger}, Jianshe Wei{dagger}, Akio Sekigawa{dagger}, Mitsuru Sato*, Shuji Kojima, Hiroshi Kitani* and Makoto Hashimoto2,{dagger}

* Transgenic Animal Research Center, National Institute of Agrobiological Sciences, Tsukuba, Japan; {dagger} Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan; {ddagger} Research Center for Prion Diseases, National Institute of Animal Health, Tsukuba, Japan; § Department of Physiology, Nippon Medical School, Tokyo, Japan; and Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-shi, Japan

Recently, autophagy has been associated with the TLR signaling pathway to eliminate intracellular pathogens in the innate immune system. However, it is unknown if other pathways regulate autophagy during the immunologic response. Given the critical role of the purinergic P2X7 receptor (P2X7R) pathway during various immunologic functions (i.e., caspase activation and IL-1β secretion), the principal objective here was to determine whether the P2X7R pathway may regulate autophagy in immune cells. We observed in both MG6 mouse microglial cells and primary microglia that activation of P2X7R by ATP increases the expression of microtubule-associated protein 1 light chain 3 (LC3)-II, the autophagosomal membrane-associated form of LC3, in an extracellular Ca2+-dependent manner. Consistent with this, immunohistochemistry showed extensive formation of LC3-immunopositive dots, and electron microscopy demonstrated accumulation of autophagosomes and autophagolysosomes in ATP-treated cells. Importantly, the up-regulation of LC3-II by P2X7R activation was not affected by autophagy inhibitors, such as 3-methyladenine and PI3K inhibitors. Furthermore, while lysosomal functions were impaired by ATP treatment, autophagolysosomal components were released into the extracellular space. Similarly, a phagocytosis assay using Escherichia coli BioParticles showed that phagosome maturation was impaired in ATP-treated cells and a robust release of LC3-immunopositive phagolysosomes was induced along with a radial extension of microtubule bundles. Taken together, the data suggest a novel mechanism whereby the P2X7R signaling pathway may negatively regulate autophagic flux through the impairment of lysosomal functions, leading to stimulation of a release of autophagolysosomes/phagolysosomes into the extracellular space.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a research grant and a Grant-in-Aid from the BSE Control Project of the Ministry of Agriculture, Forestry, and Fisheries in Japan; by Grants-in-Aid for Young Scientists (category B) and Exploratory Research from the Ministry of Education, Science, Sports and Technology of Japan; and by research grants from The Naito Foundation and The Takeda Foundation.

2 Address correspondence and reprint requests to Dr. Makoto Hashimoto, Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo 183-8526, Japan. E-mail address: hashimoto-mk{at}igakuken.or.jp

3 Abbreviations used in this paper: P2X7R, P2X7 receptor; BzATP, 3'-O-(4-benzoyl)benzoyl-ATP; BBG, brilliant blue G; oATP, oxidized ATP; LC3B, microtubule-associated protein 1 light chain 3B; 3-MA, 3-methyladenine; 2,3-DPG, 2,3-diphosphoglycerate; AMPK, AMP-activated protein kinase; S6K, S6 kinase; mTOR, mammalian targent of rapamycin; TfR, transferrin receptor; HBSS, HEPES-buffered salt solution; PLD, phospholipase D; [Ca2+]i, intracellular Ca2+ concentration.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.